Semaglutide
A GLP-1 receptor agonist widely reported for significant weight loss and appetite suppression.
People use this for
Benefit Profile
Semaglutide's fingerprint across categories
Community Interest
Report volume over 12 months
Reported Benefits
2 of 2Significant Weight Loss
Strongly Positive"Lost 40 lbs in 4 months. Nothing else ever worked like this for me."
Appetite Suppression
Strongly Positive"The food noise in my head is finally quiet. I can walk past the fridge without thinking about it."
Unexpected Findings
Interesting effects reported by users
Many users report significantly decreased desire to drink alcohol. Some former heavy drinkers report completely losing interest in alcohol within weeks of starting.
“I was a bottle-of-wine-a-night person. Week 3 on Ozempic and I literally forgot to buy wine. Just didn't think about it.”
“The alcohol thing is REAL. Used to have 2-3 beers daily for 20 years. Now? Maybe one every other week, and I don't even finish it.”
“Honestly the alcohol reduction has been almost as life-changing as the weight loss. My marriage is better. My sleep is better. Everything.”
Reported Side Effects
Common especially during dose titration, usually improves over time.
Slowed digestion can lead to constipation for some users.
Dosing Patterns
Most Popular: SubQ at 0.25-2.4 mg
95% of community members report using this dosing protocol 1x weekly. Individual responses vary — start low and adjust based on your experience.
Commonly Stacked With
Sources
(5)Frequently Asked
Semaglutide is a GLP-1 receptor agonist that slows gastric emptying, reduces appetite, and affects brain regions controlling food intake.